What the notice says
On 18 November 2026, CDC posted a Level 1 (Practice Usual Precautions) travel health notice reporting cases of multidrug-resistant (MDR) typhoid fever among travelers returning from Senegal. Level 1 is CDC's lowest alert tier: it signals an identified risk worth preparing for, not a recommendation to change or cancel travel.
Background on typhoid fever
Typhoid fever is caused by Salmonella Typhi and is transmitted through food and water contaminated with human faeces. Typical features reported in public health sources include persistent and progressively rising fever, headache, abdominal pain, malaise, and either constipation or diarrhoea. Symptoms commonly begin 1–3 weeks after exposure, so illness may start only after a traveler has returned home.
"Multidrug-resistant" means the bacterial isolates are not susceptible to several antibiotic classes historically used for typhoid. Practically, this narrows the options available to treating clinicians and makes laboratory confirmation and susceptibility testing more important, which is why CDC flags these clusters even at Level 1.
Risk-reduction measures described by public health authorities
- Vaccination: Typhoid vaccines are available in several countries in injectable and oral forms. Eligibility, timing before departure, and booster intervals differ by product and by national guidance. Importantly, no typhoid vaccine is fully protective, and vaccines do not overcome antibiotic resistance.
- Food and water precautions: Public guidance emphasises safe water sources, hot and freshly cooked food, caution with raw produce, ice, and unpasteurised dairy.
- Hand hygiene: Soap and water, particularly before eating and after toilet use.
- Post-travel illness: Travelers who develop fever during or after travel are advised to seek medical assessment promptly and to tell the clinician where they travelled and when.
Pharmacist's note
From a pharmaceutical sciences perspective, the headline here is stewardship, not panic. Two points I raise with travelers at the counter: first, pre-travel vaccine planning is time-sensitive — typhoid vaccines need lead time before departure to allow an immune response, so a pharmacy or travel-clinic conversation weeks ahead is more useful than one the day before a flight. Second, carrying or self-starting leftover antibiotics for "traveler's fever" is a poor strategy and is especially counterproductive where resistance is documented: it can delay diagnosis, reduce blood-culture yield, and select for further resistance. Fever after travel to an affected region warrants a clinical assessment with cultures, not self-treatment. Oral rehydration and antipyretic supportive care remain general self-care topics, but therapeutic decisions belong with a treating clinician.
Where to check for updates
Consult the CDC travel notice page and your own national travel health service, as notice levels and country lists are revised as surveillance data change.
This summary is public health information, not individual medical advice.